ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The Predictive Model Construction for Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy

Gao, Weitong; Liu, Qianqian; Zhou, Yang; Yang, Min; Yu, Yan*哈尔滨医科大学; y
TECHNOLOGY IN CANCER RESEARCH & TREATMENT2023DOI: 10.1177/15330338231206705
10阅读
引用收藏
分享

摘要

IntroductionIt is possible to predict immune-related adverse events (irAEs) in the treatment of immune checkpoint inhibitors (ICIs) based on clinical and hematological parameters. Nevertheless, the specific parameters which can predict irAEs are still in the exploration. The purpose of this retrospective study was to develop a predictive model for irAEs in non-small cell lung cancer (NSCLC) patients in the treatment of ICIs.MethodsResearchers enrolled NSCLC patients treated with at least 1 type of ICIs at Harbin Medical University Cancer Hospital between January 30, 2019 and December 31, 2021. Baseline parameters including demographic, clinicopathology, treatment information, and peripheral blood markers were selected retrospectively. Type, onset time, grade, and treatment of irAEs were also assessed. By analyzing the risk factors for irAEs, an irAEs prediction model was established using univariate and multivariate logistic regression.ResultsIn a total of 484 patients, 81 patients experienced 112 irAEs in which thyroid dysfunction was the most common irAE (n = 38, 33.9%) and ICI pneumonitis was the most serious irAE (n = 6, 33.3%). Finally, a prediction model based on lines and combination therapy of ICIs, ECOG performance status, neutrophils/lymphocytes ratio (NLR), platelet (PLT), and lymphocyte (LYM) was established. Multivariate logistic regression analysis showed that 2 or >= 3 lines of immunotherapy, ICIs combination therapy, and ECOG PS 1-2 were independent risk factors for irAEs. Baseline LYM was positively associated with irAEs (OR = 2.599, P = 0.048) while baseline NLR and PLT were negatively associated with irAEs (OR = 0.392, P = 0.047; OR = 0.992, P = 0.035, respectively). The model showed great prediction performance with the AUC value of 0.851 and 0.779 in the training cohort and validation cohort, respectively.ConclusionOur study identified the risk factors related to irAEs occurrence and constructed and assessed the predictive model of irAEs in patients with NSCLC treated by ICIs using clinical and hematological parameters, thus guiding clinicians to select precisely the population receiving immunotherapy and develop individualized treatment therapy.

学科与关键词

关键词
non-small cell lung cancerimmune-related adverse eventspredictive modelimmunotherapy
相关
加载中…
  • New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors
    Lin, Xuwen; Chen, Xi; Long, Xiang; Zeng, Chao; Zhang, Zhihan; Fang, Weiyi*; Xu, Ping*Respiratory Research, 2023, 24(1): 64.被引 2
  • Immune-Related Adverse Events Predict the Efficacy of Immune Checkpoint Inhibitors in Lung Cancer Patients: A Meta-Analysis
    Wang, Donghui; Chen, Cen; Gu, Yanli; Lu, Wanjun; Zhan, Ping; Liu, Hongbing; Lv, Tangfeng; Song, Yong*; Zhang, Fang*Frontiers in Oncology, 2021, 11: 631949.被引 34
  • Deep learning for predicting the risk of immune checkpoint inhibitor-related pneumonitis in lung cancer
    Cheng, M.; Lin, R.; Bai, N.; Zhang, Y.; Wang, H.; Guo, M.; Duan, X.; Zheng, J.*; Qiu, Z.*; Zhao, Y.*Clinical Radiology, 2023, 78(5): e377-e385.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
发表日期
2023
卷期
第 22 卷
页码
15330338231206705
DOI
10.1177/15330338231206705
语言
ENGLISH
成果收录
SCIE

作者

  • G

    Gao, Weitong (第一作者)

    harbin med univ

  • L

    Liu, Qianqian

查看全部 5 位作者收起作者
  • Z

    Zhou, Yang

    harbin med univ

  • Y

    Yang, Min

    harbin med univ

  • Y

    Yu, Yan (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417